Drug intelligence / Profile preview

Iscador Qu Spezial

Development stage
Unknown
Lead developer
Iscador
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Subcutaneous
01

Overview

Iscador Qu Spezial is a botanical biological preparation derived from a fermented aqueous extract of fresh European mistletoe (*Viscum album L.*) grown specifically on oak trees (*Quercus*). Developed by Iscador AG in association with the Society for Cancer Research (Verein für Krebsforschung), it is administered via subcutaneous injection. The extract is characterized by its content of viscotoxins and mistletoe lectins, which are believed to exert immune-modulating, antitumor, and antiangiogenic effects. It has been primarily investigated as a complementary or supportive treatment for advanced (stage III–IV) pancreatic cancer with the goal of improving overall survival and health-related quality of life when used alongside standard palliative chemotherapy or best supportive care. It is also used in other oncology settings, including breast, lung, and colorectal cancers, and is registered as a herbal medicinal product for well-established use in Sweden.

Brand names
Iscador Qu SpezialIscador
Other names
Viscum album Quercus extractMistletoe extract QuercusIscador Qu
02

Targets

SRL (28S ribosomal RNA sarcin–ricin loop)ASGPR (Asialoglycoprotein Receptor 1)

Beyond the preview

Go deeper on Iscador Qu Spezial.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iscador Qu Spezial.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call